comparemela.com

Polaris Trading News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A reminder to review Polaris Trading Group

A reminder to review Polaris Trading Group A quick reminder for you, Danny. Thanks again for choosing Polaris Trading Group. We would like to remind you that writing a review of your experience will help us improve our customer satisfaction. How did we do? ○ ○ ○ ○ ○ All reviews (whether good, bad, or

⭐ ⭐ ⭐ ⭐ ⭐ How many stars would you give Polaris Trading Group?

Your opinion matters Dear Danny, Thank you for choosing Polaris Trading Group. How did we do? ○ ○ ○ ○ ○ Your experience is important to us and your review (whether good, bad, or otherwise) will be posted on Trustpilot.com to help other people make more informed decisions. Thanks for your time, Polaris Trading Group

Taylor 3 Day Cycle – Polaris Trading Group

Topic: Taylor 3-Day Cycle Author: David D Dube (a.k.a. PTGDavid) Website: Polaris Trading Group Prior Session was Cycle Day 1 (CD1): Normal for CD1 as price declined and exceeded the 4033 projected target, plunging down to 4003.50 Statistical Range Extreme (screenshot). Prior range was 75 handles on 1.705M contracts exchanged. …Transition from Cycle Day 1

Taylor 3 Day Cycle – Polaris Trading Group

Topic: Taylor 3-Day Cycle Author: David D Dube (a.k.a. PTGDavid) Website: Polaris Trading Group Prior Session was Cycle Day 2 (CD2): Normal CD2 as CPI print gyrated price between TargetMaster's upper and lower statistical 2-Sigma Zones. Session settlement had price trading near the upper 3 Day Cycle Target.(4154). Prior range was 82 handles on 2.316M

Taylor 3 Day Cycle – Polaris Trading Group

Topic: Taylor 3-Day Cycle Author: David D Dube (a.k.a. PTGDavid) Website: Polaris Trading Group Prior Session was Cycle Day 3 (CD3): Three-Day Cycle Statistic was fulfilled as price traded above the CD1 Low (4132.50). It was a "Wild Ride Clyde" session as JPOW's speech gave the markets a roller coaster ride, ultimately closing near highs

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.